India's The Print news website said on the 7th, "As India and the United States falter, the world is becoming more and more dependent on China's vaccines, and if it is included in WHO 's new coronary pneumonia vaccine implementation plan (COVAX) as scheduled. Purchasing catalogues to supply developing countries in Asia, Africa and Latin America, and the international demand for Chinese vaccines will increase.”
The Print news website
The article pointed out that the raging new crown virus in India has stifled its ability to fulfill vaccine supply agreements. In the past few weeks, some major countries have been looking to buy more vaccines from China.
China's reliability as a vaccine supplier is growing, while the US and EU are slow to respond to the global outbreak. The United States, which has been busy with domestic vaccinations for months, has come under international condemnation for hoarding vaccines at the expense of global health.
The article said that the epidemic crisis in India has caused the supply of vaccines to dry up, prompting many countries to turn to China. The CEO of the "Indian Serum Research Institute", the world's largest vaccine manufacturer, Punawara, has even fled India at the most critical moment of the epidemic and ran to UK .
On January 19, 2021, Serbian medical staff hold the new crown pneumonia vaccine of China Sinopharm Group. Source: Visual China
"China has become more than the largest exporter of vaccines," said Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations. "In many countries, this has become the only option."
University of IndonesiaEpidemiology From Uruguay to Senegal to Indonesia , China's vaccine has been regarded as the only hope.
According to scientific information and analysis firm Airfinity, China has exported more vaccines than all other countries combined. India was originally the world's third largest supplier after China and the European Union, but the recent worsening of the epidemic in India has caused it to stop the supply of most vaccines in the near future.
On the 7th local time, the WHO placed Sinopharm's new crown vaccine on the emergency use list. The WHO pointed out in a statement that China's Sinopharm new crown vaccine is easy to store, making it very suitable for resource-poor environments. It is also the first vaccine to carry a vaccine vial monitor, a small label on the vaccine vial that changes color when the vaccine is heated, allowing medical staff to determine whether the vaccine is safe and available.
Nature says the Covid-19 Vaccine Implementation Plan intends to distribute 2 billion doses of vaccine globally in 2021. The world's need for China's vaccine has become more urgent given the current severe constraints on global vaccine supply.
